Moreover, another study has reported that PRKD1 mediated NFκB signaling was responsible for controlling inflammatory processes in vivo e.g. immune cell infiltration, inflammation and IL6 release, which were abrogated by employing a PRKD inhibitor in a model of experimental pancreatitis in rats (70). The gene discussed is NFKB1; the disease is pancreatitis.